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Chronic stress and pain – A plea for a concerted research programChronic functional pain syndromes have commonly been asso-
ciated with ongoing exposure to stress or with post-traumatic
stress disorder (PTSD). Considering the inherent tremendous bur-
den for the affected patients, their families and for society, it is crit-
ical that we better understand the cause and effect relationships
between chronic stress and pain.
In this context, one recently advocated approach would be to
target altered hormonal pathways [1]. The literature is now re-
plete with studies indicating that pain syndromes such as ﬁbro-
myalgia [5], chronic pelvic pain [6], certain types of low-back
pain [4] and rheumatic arthritis [10] may be associated with a
dysfunctional reactivity of the hypothalamic–pituitary–adrenal
(HPA) axis. The blunted adrenocortical reactivity (relative hypo-
cortisolism) observed in these studies may be related to chronic
exposure to stress or to PTSD (for review see [9]). One hypothe-
sis is that this may lead to a disinhibition of the secretion of
proinﬂammatory mediators by immunocompetent and glial cells,
resulting in an ongoing sensitization of nociceptive neurons and
hence in an enhanced pain sensitivity [3]. Taken together, these
ﬁndings seem to point towards the adequacy of a psychoneu-
roimmunological approach focusing on the contribution of
stress-related dysfunctional communication among the nervous,
immune and endocrine systems in pathophysiological nocicep-
tive processing.
A cautious approach, however, is essential. We should not fall
to the temptation to assume that all hypotheses made and data
collected are generalizable. In this context, Kraus and colleagues
[7] have published a very interesting study in the present issue
of Pain. The investigators used psychophysical methods to char-
acterize pain sensitivity in PTSD, a disease commonly associated
with chronic pain, current pain and pain-related disability. The
main and somewhat intriguing ﬁnding was a reduced pain sen-
sitivity (signiﬁcantly increased heat and cold pain thresholds) in
both combat veterans suffering from PTSD and combat controls
as compared to healthy controls. With longer lasting heat stim-
uli, the authors could also discriminate between veterans with
and veterans without PTSD, the former having signiﬁcantly lower
pain reports. This paper is very important since the authors are
among the ﬁrst to provide evidence that stress-related diseases
may under certain conditions be associated with a depressed
pain sensitivity rather than with an enhanced pain sensitivity.
These data raise several key issues, but some of these have been
only partly addressed by the investigators. In the following I dis-
cuss some points that may deserve particular attention and that
may constitute useful guidelines for future research on interac-
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sitivity (quantitative sensory testing) should be included as
systematically as possible. These protocols should include
threshold measurements and the computation of stimulus
response functions. This is important as slopes may have
shifted under certain conditions, without any concomitant
alterations in thresholds. Experimental measures of pain
plasticity (development of hyperalgesia and allodynia)
should also be included whenever possible. In clinical stud-
ies, these measurements should be performed in addition to
the documentation of clinical pain.
(2) Gender and age may have an impact and should be consid-
ered systematically. There may, for example, be age- and
sex-related differences in neural, endocrine and immune
functions that are relevant for the particular research topic.
(3) Time may be an important factor. In this respect, the issue of
causal relationships should be addressed. Does ongoing
stress really foster pain or does pain maintain or enhance
stress reactions? Are a minimum period and intensity of
stress required for the alteration of pain sensitivity? In addi-
tion, biochemical parameters may change over time (e.g.
secretion of stress hormones and regulation of receptors).
Longitudinal studies should help to answer these questions.
(4) Studies should be integrative or collaborative, allowing for
the parallel recording of psychological (personality, coping
strategies, etc.), neuropsychological (e.g. involvement of
altered functioning of the limbic system) and biochemical
(e.g. stress hormones, gonadal hormones and proinﬂamma-
tory cytokines) data.
(5) The effects of potential mediators should be characterized in
detail. Glucocorticoids may, for example, inhibit pain pro-
cessing via several pathways. However, glucocorticoids
may also enhance nociception. It has for instance been
shown for neuropathic pain that activated central glucocor-
ticoid receptors may induce an upregulation of NMDA recep-
tors [8]. Effects may again depend on time and also on
concentrations (see inversed U-shaped functions).
(6) The identiﬁcation of mechanisms that operate at the cellular
and molecular levels requires studies in animal models.
These investigations should be complementary to the
human studies. Adequate stress models constitute a prere-
quisite and should mimic the respective situations in
humans as closely as possible (see e.g. persistent versus
intermittent stress, [2]). Again, integrative studies incorpo-
rating behavioral, neurophysiological, endocrinological and
immunological measurements should be performed.Elsevier B.V. All rights reserved.
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cannot all be followed in every study or in each laboratory. Consid-
ering the signiﬁcance of the problem, however, both at the individ-
ual level and at the societal level, joint and coordinated efforts
should be taken to understand the complex relationships between
stress and pain so as to develop adequate diagnosis and treatment
strategies. Why not initiate a concerted research program?
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